CHOU2 PHARMA Partners with Ethos Discovery to Study Potential New Therapy for Canine Idiopathic Epilepsy ...Middle East

NARBERTH, Pa., Jan. 27, 2025 /PRNewswire/ -- Chou2 Pharma LLC, a company focused on advancing the therapeutic use of cannabinoid molecules in veterinary medicine, is pleased to announce that the company has initiated a new study in partnership with Ethos Discovery to evaluate...

Hence then, the article about chou2 pharma partners with ethos discovery to study potential new therapy for canine idiopathic epilepsy was published today ( Monday 27/01/2025 - 07:41 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CHOU2 PHARMA Partners with Ethos Discovery to Study Potential New Therapy for Canine Idiopathic Epilepsy )

Also on site :

• The 11 Biggest Ways ‘Percy Jackson’ Season 2 Changed The Sea of Monsters
• RT LAUNCHES FREE ONLINE RUSSIAN LANGUAGE COURSE FOR FOREIGNERS
• Anthropologie's $38 Bead Necklace Is the Dainty Layering Piece That 'Goes With Everything'